Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.

Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...

Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...

Under the terms of the agreement, SUP will be responsible for obtaining the necessary regulatory approvals to sell Tiotropium ...